Cellular and humoral immunity towards parental SARS-CoV-2 and variants of concern after two doses of the NVX-CoV2373-vaccine in comparison to homologous BNT162b and mRNA1273 regimens
Franziska Hielscher, View ORCID ProfileTina Schmidt, View ORCID ProfileVerena Klemis, View ORCID ProfileAlexander Wilhelm, Stefanie Marx, Amina Abu-Omar, Laura Ziegler, Candida Guckelmus, Rebecca Urschel, View ORCID ProfileUrban Sester, View ORCID ProfileMarek Widera, View ORCID ProfileMartina Sester
doi: https://doi.org/10.1101/2022.08.02.22278342
Franziska Hielscher
1Department of Transplant and Infection Immunology, Saarland University, Homburg, Germany
Tina Schmidt
1Department of Transplant and Infection Immunology, Saarland University, Homburg, Germany
Verena Klemis
1Department of Transplant and Infection Immunology, Saarland University, Homburg, Germany
Alexander Wilhelm
2Institute for Medical Virology, University Hospital Frankfurt, Goethe University Frankfurt, Germany
Stefanie Marx
1Department of Transplant and Infection Immunology, Saarland University, Homburg, Germany
Amina Abu-Omar
1Department of Transplant and Infection Immunology, Saarland University, Homburg, Germany
Laura Ziegler
1Department of Transplant and Infection Immunology, Saarland University, Homburg, Germany
Candida Guckelmus
1Department of Transplant and Infection Immunology, Saarland University, Homburg, Germany
Rebecca Urschel
1Department of Transplant and Infection Immunology, Saarland University, Homburg, Germany
Urban Sester
3Department of Nephrology, SHG-Klinikum Völklingen
Marek Widera
2Institute for Medical Virology, University Hospital Frankfurt, Goethe University Frankfurt, Germany
Martina Sester
1Department of Transplant and Infection Immunology, Saarland University, Homburg, Germany

Data Availability
All figures and tables have associated raw data. The data that support the findings of this study are available from the corresponding author upon request.
Posted August 03, 2022.
Cellular and humoral immunity towards parental SARS-CoV-2 and variants of concern after two doses of the NVX-CoV2373-vaccine in comparison to homologous BNT162b and mRNA1273 regimens
Franziska Hielscher, Tina Schmidt, Verena Klemis, Alexander Wilhelm, Stefanie Marx, Amina Abu-Omar, Laura Ziegler, Candida Guckelmus, Rebecca Urschel, Urban Sester, Marek Widera, Martina Sester
medRxiv 2022.08.02.22278342; doi: https://doi.org/10.1101/2022.08.02.22278342
Cellular and humoral immunity towards parental SARS-CoV-2 and variants of concern after two doses of the NVX-CoV2373-vaccine in comparison to homologous BNT162b and mRNA1273 regimens
Franziska Hielscher, Tina Schmidt, Verena Klemis, Alexander Wilhelm, Stefanie Marx, Amina Abu-Omar, Laura Ziegler, Candida Guckelmus, Rebecca Urschel, Urban Sester, Marek Widera, Martina Sester
medRxiv 2022.08.02.22278342; doi: https://doi.org/10.1101/2022.08.02.22278342
Subject Area
Subject Areas
- Addiction Medicine (243)
- Allergy and Immunology (525)
- Anesthesia (125)
- Cardiovascular Medicine (1434)
- Dermatology (158)
- Emergency Medicine (292)
- Epidemiology (10333)
- Gastroenterology (533)
- Genetic and Genomic Medicine (2653)
- Geriatric Medicine (255)
- Health Economics (499)
- Health Informatics (1744)
- Health Policy (791)
- Hematology (269)
- HIV/AIDS (571)
- Medical Education (276)
- Medical Ethics (83)
- Nephrology (291)
- Neurology (2483)
- Nursing (145)
- Nutrition (381)
- Oncology (1335)
- Ophthalmology (403)
- Orthopedics (152)
- Otolaryngology (239)
- Pain Medicine (172)
- Palliative Medicine (51)
- Pathology (345)
- Pediatrics (786)
- Primary Care Research (297)
- Public and Global Health (5031)
- Radiology and Imaging (902)
- Respiratory Medicine (688)
- Rheumatology (309)
- Sports Medicine (246)
- Surgery (300)
- Toxicology (45)
- Transplantation (141)
- Urology (108)